• Homa ST, Belin J, Smith AD, et al. (1980) Levels of linoleate and arachidonate in red blood cells of healthy individuals and patients with multiple sclerosis. J Neurol Neurosurg Psychiat 43, 106–110.
  • Homa ST, Conroy DM, Belin J, Smith AD, Monro JA & Zilkha KJ (1981) Fatty acid patterns of red blood cell phospholipids in patients with multiple sclerosis. Lancet, August 29 474.
  • Ovadia H & Paterson PY (1982) Effect of indomethacin treatment upon actively-induced and transferred experimental allergic encephalomyelitis (EAE) in Lewis rats. Clin Exp Immunol 49, 386–392.
  • Field EJ & Joyce G (1983) Multiple sclerosis: effect of gamma-linolenate administration upon membranes and the need for extended clinical trials of unsaturated fatty acids. Eur. Neurol. 22, 78–83.
  • Neu IS (1983) Essential fatty acids in the serum and cerebrospinal fluid of multiple sclerosis patients. Acta. Neurol. Scand. 67, 151–163.
  • Yoshida M, Takase S, Itahara K & Nakanishi T (1983) Linoleate and fatty acid compositions in the serum lipids of Japanese patients with multiple sclerosis. Acta Neurol Scand 68, 362–364. Cherayil GD (1984) Sialic acid and fatty acid concentrations in lymphocytes, red blood cells, and plasma from patients with multiple sclerosis. J Neuro Sci. 63, 1–10.
  • Dworkin RH, Bates D, Millar JHD, et al. (1984) Linoleic acid and multiple sclerosis: a reanalysis of three double blind trials. Neurology 34, 1441–1445.
  • Hirsch RL, Panitch HS & Johnson KP (1985) Lymphocytes from multiple sclerosis patients produce elevated levels of gamma interferon in vitro. J Clin Immunol 5, 386–389.
  • Harbige LS, Crawford MA, Jones R, Preece AW & Forti A (1986) Dietary intervention studies on the phosphoglyceride fatty acids and electrophoretic mobility of erythrocytes in multiple sclerosis. Prog. Lipid Res 25, 243–248
  • Fisher M, Johnson MH, Natale AM, et al. (1987) Linoleic acid levels in white blood cells, platelets and serum of multiple sclerosis patients. Acta Neurol Scand 76, 241–245.
  • Fitzgerald G, Harbige LS, Forti A & Crawford MA (1987) The effect of nutritional counselling on diet and plasma EFA status in multiple sclerosis patients over 3 years. Numan Nutrition: Applied Nutrition, 41A, 297–310.
  • Jones R & Harbige LS (1987) Erythrocytes in multiple sclerosis: effect of increased intake of essential fatty acids on phosphoglycerides and electrophoretic mobility. In Multiple Sclerosis, Immunological, Diagnostic and Therapeutic Aspects, pp. 201–209 [F Clifford Rose and R Jones, editors]. London: John Libbey & Co Ltd.
  • Beck J, Rondot P, Catinot L, et al. (1988) Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol Scand 78, 318–323.
  • Brosnan CF, Selmaj K, Raine CS. (1988) Hypothesis: a role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis, J Neuroimmunol. 1988 Apr;18(1):87-94.
  • Lawson LD, Hughes BG, 1988. Absorption of eicosapentaenoic acid and docosahexaenoic acid from fish oil triacylycerols or fish oil ethyl esters co-ingested with a high-fat meal. Biochem Biophys Res Commun. Oct 31; 156(2):960-3
  • Neuringer M, Anderson GJ & Conner WE (1988) The essentiality of n-3 fatty acids for the development and function of the retina and brain. Ann. Rev. Nutr. 8, 517–541.
  • Swank RL & Grimsgaard A (1988) Multiple sclerosis: the lipid relationship. Am. J. Clin. Nutr 48, 1387–1393.
  • Bates D, Cartlidge NEF, French JM, et al. (1989) A doubleblind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis. J Neurol Neurosurg Psychiatry 52, 18–22.
  • Holman RT, Johnson SB & Kokmen E (1989) Deficiencies of polyunsaturated fatty acids and replacement by nonessential fatty acids in plasma lipids in multiple sclerosis. Proc. Natl. Acad. Sci. USA. 86, 4720–4724.
  • Merrill JE, Strom SR, Ellison GW, et al. (1989) In vitro study of mediators of inflammation in multiple sclerosis. J Clin
    Immunol 9, 84–96.
  • Navarro X & Segura R (1989) Red blood cell fatty acids in multiple sclerosis. Acta Neurol Scand 79, 32–37.